Physician profile
Ross Alan Wodicka
NPI 1063737492
$25,415.55
in general payments reported to CMS, 2019-2025
10 companies · $7,905 in 2025
The $7,905 reported for 2025 was more than what 85% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,565 · 2020: $3,777 · 2021: $1,567 · 2022: $245 · 2023: $6,101 · 2024: $4,256 · 2025: $7,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Honoraria: $3,000 · Food and Beverage: $1,258 · Travel and Lodging: $577 · Education: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,200.00 |
| Honoraria | $3,000.00 |
| Food and Beverage | $1,258.33 |
| Travel and Lodging | $576.91 |
| Education | $225.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $12,124.62 | 2023-2025 | Aequalis Perform, Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation |
| Encore Medical, LP | $5,689.62 | 2022-2023 | Djo Surgical |
| Smith+Nephew, INC. | $3,552.80 | 2019-2025 | Na |
| Southern Edge Orthopaedics, INC. | $1,873.17 | 2020-2023 | |
| Arthrex, INC. | $1,787.44 | 2019-2023 | Arthrex |
| Heron Therapeutics, INC. | $121.84 | 2024 | Aponvie, Zynrelef |
| Depuy Synthes Sales INC. | $104.75 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $91.87 | 2022-2023 | Tapestry |
| Lima USA, INC. | $43.56 | 2019 | |
| Embody, INC. | $25.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Wodicka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.